1. Stokes JH, Pillsbury DH. The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Arch Dermatol Syphilol. 1930; 22:962-93

2. Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 2010 Mar;61(3):219-25. Epub 2009 Nov 13

3. Puch F, Samson-Villeger S et al. Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Exp Dermatol. 2008 Aug;17(8):668-74. Epub 2008 Mar 3

4. Toker L, Amar S, Bersudsky Y, Benjamin J, Klein E. The biology of tryptophan depletion and mood disorders. Isr J Psychiatry Relat Sci. 2010;47(1):46-55

5. Ledochowski M, Widner B et al. Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol 2001;36:367-371

6. Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000; 35:1048-1052

7. ledochowski M et al. Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report. Digestive Diseases and Sciences. 1998; 43(11):2513-2517

8. Varea V, de Carpi JM et al. Malabsorption of carbohydrates and depression in children and adolescents. Journal of Pediatric Gastroenterology and Nutrition. 40:561-565

9. Perica MM, Delas I. Essential Fatty acids and psychiatric disorders. Nutr Clin Pract. 2011 Aug;26(4):409-25.

10. Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011 Jul;17(3):252-66. Epub 2011 Jul 13

11. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain Behav Immun. 2011 Jul 19. [Epub ahead of print]

12. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinol Lett 2008; 29(3):1-5

13. Viana AF, Maciel IS, Dornelles FN, Figueiredo CP, Siqueira JM, Campos MM et al: Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. Neuroinflammation 2010, 7:98

14. Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-20

15. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathogens 2011, 3:1

16. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil (2011) 23, 187-192

17. Bravo JA, Scaravage E, Chew M et al. The probiotic Lactobacillus reuteri induces constitutive changes in central GABA receptor expression. SFN 2010; 795.17/FFF2.

18. Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006; 89: 35-37

19. Fetissov OS, Déchelotte P. The new link between gut-brain axis and neuropsychiatric disorders. Current Opinion in Clinical Nutrition and Metabolic Care 2011, 14:477-482

20. Bubenik GA. Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol. 2008 Aug;59 Suppl 2:33-51.

21. Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol. 2007 Dec;58 Suppl 6:97-103. Review

22. Konturek PC, Konturek SJ et al. Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans. J Pineal Res. 2010 May;48(4):318-23.

23. Kandil TS, Mousa AA et al. The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease. BMC Gastroenterol. 2010 Jan 18;10:7

24. Mozaffari S, Rahimi R, Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome: a systematic review. Curr Pharm Des. 2010;16(33):3646-55. Review.

25. Wilhelmsen M et al. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res. 2011 Doi:10.1111/j.1600-079X.2011.00895.x

26. Vogler B, Rapoport AM et al. Role of Melatonin in the Pathophysiology of Migraine. Implications for Treatment. CNS Drugs 2006; 20 (5): 343-350

27. Quera Salva MA, Hartley S et al. Circadian rhythms, melatonin and depression. Curr Pharm Des. 2011;17(15):1459-70

28. Messaoudi M, Lalonde R et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 Mar;105(5):755-64. Epub 2010 Oct 26

29. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007 Mar;61(3):355-61. Epub 2006 Dec 6

30. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, et al: A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009,1(1):6

31. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR: Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009, 29:508-18

32. O'Brien ME, Anderson H et al. SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol. 2004 Jun;15(6):906-14.